2025 US Healthcare & Life Sciences Transactions Outlook
BRG is pleased to announce new research on US healthcare and life sciences transaction activity, offering a unique point of view on the challenges and opportunities facing dealmakers in today’s regulatory environment.
The path forward for healthcare and life sciences transactions in the US is complex, and the current climate demands a deeper understanding of the forces at play. This spring, BRG will publish new research based on findings from our field survey of executives from payers, providers, and the life sciences, along with insights shared from our in-depth interviews with healthcare transaction specialists.
The report is due to be released on March 31. Register below to receive your copy.
Register to receive a copy of the report
This report will be of interest to anyone navigating the evolving landscape of healthcare and life sciences dealmaking and interested in learning more about key trends that will shape the future of dealmaking in 2025 and beyond.
Prepare for what's next.
ThinkSet magazine, a BRG publication, provides nuanced, multifaceted thinking and expert guidance that help today’s business leaders adopt a more strategic, long-term mindset to prepare for what’s next.